Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
COYA
#3330
Coya Therapeutics, Inc. Common Stock
4.9
6
+1.22%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+1.22%
Aylık değişim
+2.06%
6 aylık değişim
-25.30%
Yıllık değişim
-24.04%
Önceki kapanış
4.9
0
Open
4.9
6
Bid
Ask
Low
4.9
6
High
4.9
6
Hacim
2
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
COYA
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2022
2023
2024
TTM
Key stats
Total common shares outstanding
9.95 M
14.54 M
16.72 M
—
Valuation ratios
Enterprise value
49.12 M
77.41 M
57.53 M
287.78 M
Price to earnings ratio
-0.98
-8.81
-5.85
-21.67
Price to sales ratio
—
11.79
24.57
301.44
Price to cash flow ratio
-1.66
-6.32
-8.49
-28.15
Price to book ratio
-0.7
2.64
2.21
4.31
Enterprise value to EBITDA ratio
—
—
—
—
Profitability ratios
Return on assets %
-1.46
-0.19
-0.34
-0.5
Return on equity %
1.46
-0.22
-0.38
-0.59
Return on invested capital %
-3 242.01
-1 210.43
-1 730.96
—
Gross margin %
—
100
100
400
Operating margin %
—
-131.67
-485.35
-216 K
EBITDA margin %
—
—
—
—
Net margin %
—
-133.08
-418.7
-155.99 K
Liquidity ratios
Quick ratio
—
—
—
—
Current ratio
1.88
8.15
11.59
36.58
Inventory turnover
—
—
—
—
Asset turnover
—
0.24
0.08
0.12
Solvency ratios
Debt to assets ratio
—
—
—
—
Debt to equity ratio
—
—
—
—
Long term debt to total assets ratio
1.54
—
—
—
Long term debt to total equity ratio
-1.54
—
—
—
Per share metrics
Operating cash flow per share
-2.79
-1.1
-0.68
-0.74
EBIT per share
—
—
—
—
EBITDA per share
—
—
—
—
Total debt per share
—
—
—
—
Cash per share
2.29
3.21
2.51
8.1
Net current asset value per share
2.77
4.05
2.91
9.12
Tangible book value per share
-6.64
2.64
2.6
7.92
Working capital per share
1.3
3.56
2.66
8.12
Book value per share
-6.64
2.64
2.6
7.92
Haberler
H.C. Wainwright, Coya Therapeutics hissesi için Al notunu 18 dolar hedefiyle yineledi
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock with $18 target
Coya Therapeutics özel yerleşimde 11,1 milyon dolar sağladı
Coya Therapeutics secures $11.1 million in private placement
Coya Therapeutics advances ALS and FTD clinical trials in 2026
H.C. Wainwright, Coya Therapeutics hissesi için Al tavsiyesini 18 dolar hedefle yineledi
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock at $18
Tracking David Einhorn’s Greenlight Capital Portfolio – Q3 2025 Update (NYSE:GRBK)
H.C. Wainwright, Coya Therapeutics hissesi için Al tavsiyesini yineliyor
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock
H.C. Wainwright, Coya Therapeutics hissesi için Al tavsiyesini 18 dolar hedefle yineledi
H.C. Wainwright reaffirms Buy rating on Coya Therapeutics stock at $18 target